Rite Aid closed the most recent trading day at $8.81, moving -0.79% from the previous trading session. This move lagged the S&P 500's daily loss of 0.21%. At the same time, the Dow lost 0.46%, and the tech-heavy Nasdaq lost 0.16%.
Heading into today, shares of the drugstore chain had lost 17.95% over the past month, lagging the Retail-Wholesale sector's gain of 2.62% and the S&P 500's gain of 2.07% in that time.
Wall Street will be looking for positivity from RAD as it approaches its next earnings report date. On that day, RAD is projected to report earnings of $0 per share, which would represent year-over-year growth of 100%. Meanwhile, our latest consensus estimate is calling for revenue of $5.37 billion, down 0.31% from the prior-year quarter.
Investors might also notice recent changes to analyst estimates for RAD. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 66.67% lower. RAD is holding a Zacks Rank of #5 (Strong Sell) right now.
Looking at its valuation, RAD is holding a Forward P/E ratio of 44.4. For comparison, its industry has an average Forward P/E of 12.64, which means RAD is trading at a premium to the group.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 236, which puts it in the bottom 8% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Image: Bigstock
Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know
Rite Aid closed the most recent trading day at $8.81, moving -0.79% from the previous trading session. This move lagged the S&P 500's daily loss of 0.21%. At the same time, the Dow lost 0.46%, and the tech-heavy Nasdaq lost 0.16%.
Heading into today, shares of the drugstore chain had lost 17.95% over the past month, lagging the Retail-Wholesale sector's gain of 2.62% and the S&P 500's gain of 2.07% in that time.
Wall Street will be looking for positivity from RAD as it approaches its next earnings report date. On that day, RAD is projected to report earnings of $0 per share, which would represent year-over-year growth of 100%. Meanwhile, our latest consensus estimate is calling for revenue of $5.37 billion, down 0.31% from the prior-year quarter.
Investors might also notice recent changes to analyst estimates for RAD. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 66.67% lower. RAD is holding a Zacks Rank of #5 (Strong Sell) right now.
Looking at its valuation, RAD is holding a Forward P/E ratio of 44.4. For comparison, its industry has an average Forward P/E of 12.64, which means RAD is trading at a premium to the group.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 236, which puts it in the bottom 8% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.